Prostate Cancer Summit
New - Read October 2016 Newsletter update on the progress of prostate summit actions
Have a say! Complete this short survey on integrated models of care in prostate cancer
Watch the prostate cancer summit data presentation
Seventy-one delegates providing care or support to men with prostate cancer attended the summit on Friday 27th May to discuss and identify unwarranted variations in practice and cancer outcomes that could be addressed through state-wide action.
Professor Robert Thomas, Chief Advisor on Cancer (DHHS), opened the event and introduced the Prostate Cancer Optimal Care Pathway (OCP), highlighting the role of collaboration in addressing variations in cancer care for men with prostate cancer. Prof. Damien Bolton, Co-Chair of the Prostate Summit Working Party, set the scene and outlined the purpose of the day. A/Prof Jeremy Millar, Co-Chair of the Prostate Summit Working Party, presented available data on incidence, survival, disease characteristics and treatment planning of men with prostate cancer across Victoria. View the prostate summit presentation.
A summary of variations in practice and outcomes for Victorian men with prostate cancer was available to participants as a reference.
Prostate cancer care in Victoria presentation highlights:
- Age-standardised incidence of prostate cancer fell 39% from 2009-2014. This is highly correlated with the decreasing number of PSA tests
- Age-standardised mortality of prostate cancer increased from 1982-1994, then fell 2.5% per annum from 1994-2014
- Lower age-standardised incidence in GRICS and WCMICS, and higher in NEMICS and SMICS. This is partly explained by the higher incidences at higher Socio-economic Status (SES)
- Men in regional areas are more likely to present with symptoms, have a TURP for diagnosis, and have metastatic and high-risk disease
- In regional areas men are less likely to be recorded as discussed in an MDM, and time from diagnosis to treatment is longer
- Prostatectomies are the most common treatment, performed in 42 hospitals, more commonly in metro and private facilities
- Large variation in modalities of treatment across state even for similar risk disease
- Large variation in age-standardised mortality across regions associated with large variation in populations, disease presentation, access to care, and types of care available
Following the data presentation delegates engaged in small group discussions to identify state or local opportunities for action.
The Prostate Tumour Summit Clinical Working Party are formulating a plan of activities for the next12 months for state-wide and local implementation. This will be presented to the Victorian Integrated Cancer Services Network July 2016.
You will be invited to participate in these activities and can expect regular updates from your local ICS, Cancer Council Clinical Networks and the working party on the progress of post-summit actions.
If you are interested in being involved please contact:
Project officer - Prostate Cancer Summit
Ph 03 4215 0458
Prostate Summit Working Party
|A/Prof Jeremy Millar||A/Prof Damien Bolton||A/Prof Paul Mitchell|
|A/Prof Declan Murphy||A/Prof Justin Tse||Prof Ian Davis|
|A/Prof Sue Evans||Dr Keen-Hun Tai||Dr David Pook|
|Mr Mark Frydenberg||Mr Paul Kearns||Mr Rohan Hall|
|Mr Nathan Lawrentschuk||Dr Mahesh Iddawela||Mr Lachlan Dodds|
|Ms Mirela Matthews||Ms Melinda Williams||Mr Luc te Marvelde|
|Mr Don Vincendese||Ms Ella Stuart||Ms Megan Dendle|